1. Home
  2. TSE vs NXL Comparison

TSE vs NXL Comparison

Compare TSE & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinseo PLC

TSE

Trinseo PLC

HOLD

Current Price

$0.46

Market Cap

19.9M

Sector

Industrials

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.64

Market Cap

18.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSE
NXL
Founded
2010
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.9M
18.6M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
TSE
NXL
Price
$0.46
$0.64
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$1.00
$5.00
AVG Volume (30 Days)
1.6M
185.1K
Earning Date
02-11-2026
03-13-2026
Dividend Yield
4.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,133,800,000.00
$156,931.00
Revenue This Year
N/A
$38.28
Revenue Next Year
$4.11
$185.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$0.54
52 Week High
$5.99
$3.87

Technical Indicators

Market Signals
Indicator
TSE
NXL
Relative Strength Index (RSI) 37.03 37.58
Support Level $0.44 $0.61
Resistance Level $0.95 $0.77
Average True Range (ATR) 0.09 0.06
MACD -0.00 0.01
Stochastic Oscillator 3.86 29.14

Price Performance

Historical Comparison
TSE
NXL

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: